Development of hepatocellular carcinoma long after sustained viral response to interferon therapy in patients with chronic hepatitis C - Fat accumulation may contribute to the carcinogenesis

被引：0
|
作者：
Kurihara, H [1 ]
Tanaka, A [1 ]
Uegaki, S [1 ]
Aida, J [1 ]
Nagashima, I [1 ]
Shiga, J [1 ]
机构：
[1] Teikyo Univ, Sch Med, Tokyo 173, Japan
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [31] Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis type C after interferon therapy
    Ishibashi, K
    Kashiwagi, T
    Suzuki, T
    Isoo, Y
    Nagasawa, M
    Toyama, T
    Ozaki, S
    Naito, M
    Azuma, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1290 - A1290
  • [32] Development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha
    Hirashima, N
    Mizokami, M
    Orito, E
    Koide, T
    Itazu, I
    Kumada, K
    Sakakibara, K
    Kano, H
    Lau, JY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (10) : 955 - 958
  • [33] EXAMINATION OF INHIBITION OF HEPATOCELLULAR CARCINOMA RESULTING FROM TREATMENT OF CHRONIC HEPATITIS C WITH INTERFERON PLUS RIBAVIRIN - HEPATOCELLULAR CARCINOMA IS INHIBITED IN PATIENTS WITH SUSTAINED VIRAL RESPONSE AND SUSTAINED BIOCHEMICAL RESPONSE
    Nakajima, Jun
    Ikeda, Atsuyuki
    Saito, Sumio
    Kimura, Taru
    Osaki, Yukio
    HEPATOLOGY, 2009, 50 (04) : 710A - 710A
  • [34] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy: a large scale, long-term cohort study
    Nagaoki, Yuko
    Aikata, Hiroshi
    Kan, Hiromi
    Fujino, Hatsue
    Kobayashi, Tomoki
    Fukuhara, Takayuki
    Masaki, Keiichi
    Nakahara, Takashi
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Ochi, Hidenori
    Chayama, Kazuaki
    HEPATOLOGY, 2015, 62 : 727A - 727A
  • [35] RISK FACTORS FOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY
    Chang, K. -C.
    Hu, T. -H.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S164 - S164
  • [36] Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C
    Sugimachi, Keishi
    Kinjo, Nao
    Ikebe, Masahiko
    Yamashita, Naoki
    Kajiwara, Eiji
    Mimori, Koshi
    Higashi, Hidefumi
    HEPATOLOGY RESEARCH, 2013, 43 (06) : 605 - 609
  • [37] Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C
    Ikeda, M
    Fujiyama, S
    Tanaka, M
    Sata, M
    Ide, T
    Yatsuhashi, H
    Watanabe, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 122 - 128
  • [38] ADIPOCYTOKINE INVOLVEMENT WITH HEPATOCELLULAR CARCINOMA OCCURRING AFTER SUSTAINED VIROLOGICAL RESPONSE TO INTERFERON FOR CHRONIC HEPATITIS C
    Fukushima, Nobuyoshi
    Kuromatsu, Ryoko
    Arinaga, Teruko
    Ide, Tatsuya
    Torimura, Takuji
    Sata, Michio
    HEPATOLOGY, 2008, 48 (04) : 498A - 498A
  • [39] Long-term outcomes after hepatic resection for hepatocellular carcinoma in patients with sustained virological responses to interferon therapy for chronic hepatitis C
    Tanaka, Shogo
    Takemura, Shigekazu
    Tamori, Akihiro
    Kinoshita, Masahiko
    Kawada, Norifumi
    Kubo, Shoji
    HEPATOLOGY, 2015, 62 : 1060A - 1061A
  • [40] Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection
    Ida, Hiroshi
    Hagiwara, Satoru
    Kono, Masashi
    Minami, Tomohiro
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Takita, Masahiro
    Yada, Norihisa
    Minami, Yasunori
    Ueshima, Kazuomi
    Nishida, Naoshi
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2017, 35 (06) : 565 - 573
12345